1Salem, LC, Andersen, BB, Nielsen, TR, Stokholm, J, Jørgensen, MB, Waldemar, G. Inadequate diagnostic evaluation in young patients registered with a diagnosis of dementia: a nationwide register-based study. Dement Geriatr Cogn Dis Extra 2014; 4: 31–44.
2Konijnenberg, E, Fereshtehnejad, SM, Ten Kate, M, Eriksdotter, M, Scheltens, P, Johannsen, P, et al. Early-onset dementia: frequency, diagnostic procedures, and quality indicators in three European tertiary referral centers. Alzheimer Dis Assoc Disord 2017; 31: 146–51.
3Ngo, J, Holroyd-Leduc, JM. Systematic review of recent dementia practice guidelines. Age Ageing 2015; 41: 25–33.
4Filippi, M, Agosta, F, Barkhof, F, Dubois, B, Fox, NC, Frisoni, GB, et al. EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol 2012; 19: 1487–501.
5Rossor, MN, Fox, NC, Mummery, CJ, Schott, JM, Warren, JD. The diagnosis of young-onset dementia. Lancet Neurol 2010; 9: 793–806.
6Sorbi, S, Hort, J, Erkinjuntti, T, Fladby, T, Gainotti, G, Gurvit, H, et al. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012; 19: 1159–79.
7Lehmann, M, Koedam, EL, Barnes, J, Bartlett, JW, Ryan, NS, Pijnenburg, YA, et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging 2012; 33: 627.e1-627.e12.
8Harris, PB. The perspective of younger people with dementia: still an overlooked population. Soc Work Ment Health 2004; 2: 17–36.
9Johannessen, A, Möller, A, Moller, A. Experiences of persons with early-onset dementia in everyday life: a qualitative study. Dementia 2013; 12: 410–24.
10Crutch, SJ, Lehmann, M, Schott, JM, Rabinovici, GD, Rossor, MN, Fox, NC. Posterior cortical atrophy. Lancet Neurol 2012; 11: 170–8.
11Mendez, MF. Early-onset Alzheimer disease. Neurol Clin 2017; 35: 263–81.
12Graham, A, Hodges, J. Frontotemporal dementia. Psychiatry 2005; 4: 55–58.
13Gorno-Tempini, M, Hillis, A, Weintraub, S, Kertesz, A, Mendez, M, Cappa, S, et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006–14.
14Palasí, A, Gutiérrez-Iglesias, B, Alegret, M, Pujadas, F, Olabarrieta, M, Liébana, D, et al. Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold? J Neurol 2015; 262: 1238–46.
15Rascovsky, K, Hodges, JR, Knopman, D, Mendez, MF, Kramer, JH, Neuhaus, J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456–77.
16Carter, JE, Oyebode, JR, Koopmans, RTCM. Young-onset dementia and the need for specialist care: a national and international perspective. Aging Ment Heal J 2018; 22: 468–73.
17Williams, T, Dearden, AM, Cameron, IH. From pillar to post – a study of younger people with dementia. Psychiatr Bull 2001; 25: 384–7.
18Rosness, TA, Haugen, PK, Passant, U, Engedal, K. Frontotemporal dementia––a clinically complex diagnosis. Dialogues Clin Neurosci 2008; 23: 837–42.
19van Vliet, D, de Vugt, ME, Bakker, C, Pijnenburg, YA, Vernooij-Dassen, MJ, Koopmans, RT, et al. Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychol Med 2013; 43: 423–32.
20Draper, B, Cations, M, White, F, Trollor, J, Loy, C, Brodaty, H, et al. Time to diagnosis in young-onset dementia and its determinants: the INSPIRED study. Int J Geriatr Psychiatry 2016; 31: 1217–24.
21Draper, B, Cations, M, White, F, Trollor, J, Loy, C, Brodaty, H, et al. Time to diagnosis in young-onset dementia and its determinants: the INSPIRED study. Int J Geriatr Psychiatry 2016; 31: 1217–24.
22Oyebode, JR, Bradley, P, Allen, JL. Relatives’ experiences of frontal-variant frontotemporal dementia. Qual Health Res 2013; 23: 156–66.
23Woolley, JD, Khan, BK, Murthy, NK, Miller, BL, Rankin, KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psych 2011; 72: 126–33.
24Passant, U, Elfgren, C, Englund, E, Gustafson, L. Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Dement Geriatr Cogn Disord 2005; 19: S15–8.
25Eriksson, H, Fereshtehnejad, SM, Falahati, F, Farahmand, B, Religa, D, Eriksdotter, M. Differences in routine clinical practice between early and late onset Alzheimer's disease: data from the Swedish Dementia Registry. J Alzheimer's Dis 2014; 41: 411–9.
26Rosness, TA, Engedal, K, Chemali, Z. Frontotemporal dementia: an updated clinician's guide. J Geriatr Psychiatry Neurol 2016; 29: 271–80.
27Ridha, B, Josephs, K. Young-onset dementia: a practical approach to diagnosis. Neurologist 2006; 12: 2–13.
28Kuruppu, DK, Matthews, BR. Young-onset dementia dulanji. Semin Neurol 2013; 33: 365–85.
29Ferrari, C, Nacmias, B, Sorbi, S. The diagnosis of dementias: a practical tool not to miss rare causes. Neurol Sci 2018; 39: 615–27.
30Arksey, H, O'Malley, L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005; 1: 19–32.
31Greenhalgh, T, Peacock, R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. Br Med J 2005; 331: 1064–5.
32Ahmed, S, Baker, I, Butler, CR. Diagnosing young onset dementia can be challenging. Practitioner 2016; 260: 11–8.
33Snowden, JS, Thompson, JC, Stopford, CL, Richardson, AMT, Gerhard, A, Neary, D, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134: 2478–92.
34Joshi, A, Ringman, JM, Lee, AS, Juarez, KO, Mendez, MF. Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease. J Neurol 2012; 259: 2182–8.
35Goldman, JS. Genetic testing and counseling in the diagnosis and management of young-onset dementias. Psychiatr Clin North Am 2015; 38: 295–308.
36Goldman, JS, Rademakers, R, Huey, ED. An algorithm for genetic testing of frontotemporal lobar degeneration. Neurology 2011; 76: 475–483.
37Yesavage, JA, Brink, TL, Rose, TL, Lum, O, Huang, V, Adey, M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17: 37–49.
38Hamilton, M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50–5.
39Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
40Cummings, JL, Mega, M, Gray, K, Rosenberg-Thompson, S, Carusi, DA, Gornbein, J. The Neuropsychiatric Inventory. Neurology 1994; 44: 2308.
41Funkiewiez, A, Bertoux, M, de Souza, LC, Lévy, R, Dubois, B. The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. Neuropsychology 2012; 26: 81–90.
42Piguet, O, Hornberger, M, Mioshi, E, Hodges, JR. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 2011; 10: 162–72.
43Nasreddine, ZS, Phillips, NA, Bédirian, V, Charbonneau, S, Whitehead, V, Collin, I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695–9.
44Mathuranath, PS, Nestor, PJ, Berrios, GE, Rakowicz, W, Hodges, JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55: 1613–20.
45Dubois, B, Slachevsky, A, Litvan, I, Pillon, B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621–6.
46Reul, S, Lohmann, H, Wiendl, H, Duning, T, Johnen, A. Can cognitive assessment really discriminate early stages of Alzheimer's and behavioural variant frontotemporal dementia at initial clinical presentation? Alzheimer's Res Ther 2017; 9: 1–12.
47Ritter, AR, Leger, GC, Miller, JB, Banks, SJ. Neuropsychological testing in pathologically verified Alzheimer's disease and frontotemporal dementia: how well do the Uniform Data Set measures differentiate between diseases? Alzheimer Dis Assoc Disord 2017; 31: 187–91.
48Likeman, M, Anderson VM, JM, Stevens, JM, Waldman, AD, Godbolt, AK, Frost, C, et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol 2005; 62: 1410–5.
49Johnson, KA, Minoshima, S, Bohnen, NI, Donohoe, KJ, Foster, NL, Herscovitch, P, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimer's Dement 2013; 9: E1–16.
50Laforce, R, Rosa-Neto, P, Soucy, JP, Rabinovici, GD, Dubois, B, Gauthier, S. Canadian consensus guidelines on use of amyloid imaging in Canada: update and future directions from the specialized task force on amyloid imaging in Canada. Can J Neurol Sci 2016; 43: 503–12.
51Balasa, M, Sanchez-Valle, R, Antonell, A, Bosch, B, Olives, J, Rami, L, et al. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment. J Alzheimers Dis 2014; 40: 919–27.
52Molinuevo, JL, Blennow, K, Dubois, B, Engelborghs, S, Lewczuk, P, Perret-Liaudet, A, et al. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimer's Dement 2014; 10: 808–17.
53Goldman, JS, Hahn, SE, Catania, JW, Larusse-Eckert, S, Butson, MB, Rumbaugh, M, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011; 13: 597–605.
54Bozeat, S, Gregory, CA, Ralph, MAL, Hodges, JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal d. Psychiatry Interpers Biol Process 2000; 69: 178–86.
55Shinagawa, S, Nakajima, S, Plitman, E, Graff-Guerrero, A, Mimura, M, Nakayama, K, et al. Psychosis in frontotemporal dementia. J Alzheimers Dis 2014; 42: 485–99.
56Rosness, TA, Engedal, K, Chemali, Z. Frontotemporal dementia: an updated clinicians guide. J Geriatr Psychiatry Neurol 2016; 29: 271–80.
57Bakker, C, De Vugt, ME, Van Vliet, D, Verhey, FR, Pijnenburg, YA, Vernooij-Dassen, MJ, et al. The relationship between unmet care needs in young-onset dementia and the course of neuropsychiatric symptoms: a two-year follow-up study. Int Psychogeriatrics 2014; 26: 1991–2000.
58Landqvist Waldö, M, Gustafson, L, Passant, U, Englund, E. Psychotic symptoms in frontotemporal dementia: a diagnostic dilemma? Int Psychogeriatrics 2015; 27: 531–9.
59Sha, SJ, Takada, LT, Rankin, KP, Yokoyama, JS, Rutherford, NJ, Fong, JC, et al. Frontotemporal dementia due to C9ORF72 mutations Clinical and imaging features. Neurology 2012; 79: 1002–11.
60Weintraub, S, Salmon, D, Mercaldo, N, Ferris, S, Graff-radford, NR, Chui, H, et al. The Alzheimer's Disease Centers’ data set (UDS): the neuropsychological test battery. Alzheimer Dis Assoc Disord 2009; 23: 91–101.
61Rosness T, A, Engedal, K, Chemali, Z. Raising the bar: a comparative analysis of patients with early onset Alzheimer's disease. Int Psychogeriatr 2014; 26: 1–2.
62Quach, C, Hommet, C, Mondon, K, Lauvin, MA, Cazals, X, Cottier, JP. Early-onset dementias: specific etiologies and contribution of MRI. Diagn Interv Imaging 2014; 95: 377–98.
63Pereira, JB, Cavallin, L, Spulber, G, Aguilar, C, Mecocci, P, Vellas, B, et al. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med 2014; 275: 317–30.
64Ferreira, D, Cavallin, L, Larsson, E-M, Muehlboeck, J-S, Mecocci, P, Vellas, B, et al. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. J Intern Med 2015; 278: 277–90.
65Koric, L, Guedj, E, Habert, MO, Semah, F, Branger, P, Payoux, P, et al. Molecular imaging in the diagnosis of Alzheimer's disease and related disorders. Rev Neurol (Paris) 2016; 172: 725–34.
66Carswell, CJ, Win, Z, Muckle, K, Kennedy, A, Waldman, A, Dawe, G, et al. Clinical utility of amyloid PET imaging with (18) F-florbetapir: a retrospective study of 100 patients. J Neurol Neurosurg Psychiatry 2018; 89: 294–9.
67Sheikh-Bahaei, N, Sajjadi, SA, Pierce, AL. Current role for biomarkers in clinical diagnosis of Alzheimer disease and frontotemporal dementia. Curr Treat Options Neurol 2017; 19: 46.
68Miller, A-M, Balasa, M, Blennow, K, Gardiner, M, Rutkowska, A, Scheltens, P, et al. Current approaches and clinician attitudes to the use of cerebrospinal fluid biomarkers in diagnostic evaluation of Dementia in Europe. J Alzheimers Dis 2017; 60: 201–10.
70Hoilund-Carlsen, PF, Barrio, JR, Gjedde, A, Werner, TJ, Alavi, A. Circular inference in dementia diagnostics. J Alzheimer's Dis 2018; 63: 69–73.
71Ceccaldi, M, Jonveaux, T, Verger, A, Krolak-Salmon, P, Houzard, C, Godefroy, O, et al. Added value of F-18-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: a naturalistic study. Alzheimers Dement 2018; 14: 293–305.
72van Vliet, D, de Vugt, ME, Bakker, C, Koopmans, RT, Pijnenburg, YA, Vernooij-Dassen, MJ, et al. Caregivers’ perspectives on the pre-diagnostic period in early onset dementia: a long and winding road. Int Psychogeriatrics 2011; 23: 1393–404.
73Rodda, J, Carter, JE. A survey of UK services for younger people living with dementia. Int J Geriatr Psychiatry 2016; 31: 957–9.
75Doyle, C, Jackson, D, Loi, S, Malta, S, Moore, K. Videoconferencing and telementoring about dementia care: evaluation of a pilot model for sharing scarce old age psychiatry resources. Int Psychogeriatr 2016; 28: 1567–74.